Stockmarkets

Markets: interest rate cut boosts FTSE 100

The FTSE 100 saw a sharp rise yesterday after the Bank of England cut interest rates to 0.25% and extended its quantitative easing programme. The index closed up 1.6% at 6,740.

The US booms and China starts spending again: is the bear market over?

A grim Christmas trading period has given way to New Year euphoria. John Stepek looks at whether it really is time to celebrate, and explains what it means for your money.

The charts that matter: Apple tumbles, US jobs boom

Apple’s profit warning is an unnerving sign for investors that times are changing. John Stepek looks at what’s changed in the global economy’s most important charts.

Why Apple’s sales warning has rattled the currency markets

Apple’s admission that sales will be lower than expected is clearly a problem for the tech giant. But it has much bigger implications for the global economy as a whole. John Stepek explains why.

2018 was a bad year for investors, for pretty obvious reasons

Investors had a rough 2018 with many indices ending the year in bear markets. John Stepek looks at what was behind it all, and where markets might go in 2019.

Uber IPO to be 2019’s crucial test case

The flotation of the world’s biggest ride-hailing app will be a pivotal moment for equity markets, says Matthew Lynn.

Emerging markets are the ‘buy of the decade’

Emerging markets account for most of the world’s ten worst-performing equity indices in 2018, but that doesn’t mean emerging markets in general are in crisis.

Britain is in the bargain basement

Our stockmarket has been an international pariah this year – all the more reason to snap up some deals.

Money printing turns to money burning

The latest decision on interest rates from the Fed provided no comfort to markets – indeed, it supplied the impetus for the latest sell-off.

The MoneyWeek Christmas quiz

Facebook flopped, Disney dazzled, Elon Musk picked a fight and there was a case of mistaken identity on Wall Street. How much financial news of 2018 do you remember? Try the MoneyWeek Christmas quiz.

Pharmaceutical companies ditch their consumer healthcare arms

GSK and Pfizer are merging their consumer-healthcare businesses. GSK can now concentrate on its drugs pipeline. Alex Rankine reports.

Showing page 8 of 518

 

Don’t wait until March
Take back control of your investments NOW
Try 6 free issues then pay only £2.45 per issue
(normally £4.25)
Turn a no deal into a profitable one
SUBSCRIBE TO MONEYWEEK NOW